Results 191 to 200 of about 680,873 (331)

Urachal adenocarcinoma: a case report and literature review. [PDF]

J Surg Case Rep
Kostara K, Palmisano L, Shenasan P, El Sedfy A, Christian D.   +4 more
europepmc   +1 more source

The clinical benefits of [18F]AlF-NOTA-octreotide PET/CT in staging and restaging patients with gastroenteropancreatic neuroendocrine neoplasms: comparison of [18F]FDG PET/CT [PDF]

Donghe Chen, Zhongfan Liu, Guolin Wang, Mengjiao Tu, Fei Yang, Chunting Jiang, Kui Zhao, Xinhui Su   +7 more
openalex   +1 more source

A Novel Staging System and Clinical Predictive Nomogram for More Accurate Staging and Prognosis of Malignant Pancreatic Intraductal Papillary Mucinous Neoplasms: A Population-Based Study [PDF]

, 2020
Haoxiang Zhang, Chenggang Gao, Jiaoshun Chen, Shihong Wu, Jianwei Bai, Tao Yin   +5 more
openalex   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Appendiceal Collision Tumors: An Institutional Case Series and Systematic Review of the Histologic Spectrum, Clinical Outcomes, and Management Strategies. [PDF]

Diagnostics (Basel)
Issin G, Demir F, Cagatay DV, Guvendir I, Simsek HA, Zemheri IE.   +5 more
europepmc   +1 more source

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

Journal of Clinical Oncology, 2004
D. Pfister, David H. Johnson, C. Azzoli, W. Sause, Thomas J. Smith, Sherman Baker, J. Olak, D. Stover, John R. Strawn, A. Turrisi, M. Somerfield   +10 more
semanticscholar   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

Localization, clinical and pathological characteristics of the colon cancer patients aged up to 40 years and over 65 years [PDF]

Archive of Oncology, 2002
Josifovski Jeremija, Manojlović Nebojša, Pupić Gordana S., Radošević-Jelić Ljiljana M.   +3 more
doaj   +1 more source

Not all penile tumours are alike: A rare case of penile melanoma. [PDF]

Urol Case Rep
Gil M, Carneiro JC, Meireles A, Campos Pinheiro L.   +3 more
europepmc   +1 more source

The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinoma

Liver transplantation, 2004
J. Llovet, J. Fuster, J. Bruix
semanticscholar   +1 more source